The fluoropolymers in healthcare market is poised for substantial growth, with an estimated market value of USD 472.4 million in 2023 and a projected valuation of USD 792.9 million by 2033, reflecting a CAGR of 5.3% during the forecast period. Fluoropolymers, known for their exceptional chemical resistance, biocompatibility, and durability, are increasingly being used in a variety of healthcare applications, from medical devices and implantable components to drug delivery systems and surgical equipment.
The rising demand for advanced medical solutions and minimally invasive procedures is driving the adoption of fluoropolymers, particularly in applications requiring high performance and safety standards. These materials are crucial for components like catheters, surgical instruments, and diagnostic devices, where reliability and performance are critical. Fluoropolymers’ resistance to chemical degradation and their ability to withstand high temperatures and harsh conditions make them ideal for use in the stringent healthcare environment.
With advances in medical technology and growing emphasis on patient safety, fluoropolymers are becoming increasingly important in the development of next-generation healthcare products. The market growth is also supported by the increasing use of biocompatible materials in long-term implants, where fluoropolymers help minimize the risk of adverse reactions and improve patient outcomes.
Key Takeaways:
- The fluoropolymers in healthcare market is expected to grow from USD 472.4 million in 2023 to USD 792.9 million by 2033, at a CAGR of 5.3%.
- Rising demand for advanced medical devices and materials with high chemical resistance and biocompatibility is driving market growth.
- Fluoropolymers are critical for use in implantable components, drug delivery systems, and surgical instruments.
- The growth of minimally invasive procedures and innovations in medical technology are further fueling the adoption of fluoropolymers.
Tailored Fluoropolymer Applications Boost the Competitive Market’s Revenue Stream
Top 10 players capture about 40-45% of overall revenue. Fluoropolymer manufacturers are focusing on developing multipurpose products, such as standard as well as customized or compounded products. They are looking to equip their offerings with innovative technologies to cater to high-end applications.
Mergers & acquisitions (M&A) is another key focus point for global market players. DIC Corporation has developed a novel polyester plasticizer made from biomass resources and has earned the “Biomass 100%” Biomass Mark.
Korean joint venture – Mitsui Chemicals & SKC Polyurethanes Inc. – has manufactured ECONYKOL™ bio-polyol, which is raw material for plant-sourced biomass plastics that help curb ecological impact. The product has been adopted for polyurethane (PU) cushioning in seats of Robocar™ self-driving cars.
Honeywell International Inc. has launched a breakthrough platform of liquid heat transfer agents that cool high-performance electronics more effectively compared to conventional techniques that utilize water and air. In addition, the company has rolled out 30 Series IP Cameras, which is a new set of video cameras that steps up infrastructure safety and security via advanced analytics and secure channel encryption.
3M Company has acquired Acelity, Inc. and its KCI subsidiaries. Further, the company has entered into a royalty-bearing patent license agreement with LG-Innotek (LGIT) to leverage 3M’s metal mesh technology.
Daikin Industries Ltd. has acquired Heroflon, whose product assembly consists of micro-powders and fluoropolymer compounds derived from PTFE.
Lonza has entered into collaboration with Mesoblast to commercially develop Mesoblast lead allogeneic (off-the-shelf) cell therapy product – remestemcel-L – for pediatric steroid-refractory acute graft versus host disease (aGVHD).
Key Players
- DIC Corporation
- AGC Inc.
- Dongyue Group Ltd.
- Solvay S.A.
- PolyOne Corporation
- Kaneka Corp.
- Arkema Group
- Saint Gobain S.A.
- The Chemours Company
A Full Report Overview
Key Segments
By Product Type:
- PTFE
- PVDF
- PVF
- FEP
- PCTFE
- PFA
- Others
By Application:
- Medical Devices
- Hospital Disposable
- Pharma Packaging
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
